NCT04445753

Brief Summary

Aim: The aim of the present study is to examine with B-type natriuretic peptide (pro-BNP) and echocardiographic parameters and to measure life quality the effects of the 12-week Tai-Chi exercise program on cardiovascular responses in patients with heart failure in Turkey. In addition, four basic research questions have been identified for the purpose of the research: Methods:Randomized controlled trial will be carried out in the cardiology outpatient clinic in Turkey. The research will include two groups, an intervention (n=23) and a control (n=23). Cardiovascular responses will be measured with Pro-BNP, transthoracic echocardiography and six minutes walking test; Quality of life measurements with Left Ventricular Dysfunction Scale (LVD-36).Tai-Chi exercises will be carried out for a total of 12 weeks, with 2 sessions each week and one hour each session for intervention group. In addition, initially, approximately 45 minutes of heart failure education will be given to both the intervention and control groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 29, 2020

Completed
26 days until next milestone

First Posted

Study publicly available on registry

June 24, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2021

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

1.2 years

First QC Date

May 29, 2020

Last Update Submit

September 13, 2024

Conditions

Keywords

heart failurequality of lifeTai Chi

Outcome Measures

Primary Outcomes (2)

  • Pro-BNP levels (pg/ml)

    Biomarker to be used to estimate the prognosis of heart failure. The blood taken into 2ml EDTA tubes will be studied.

    3-months

  • Transthoracic Echocardiography measurements

    Transthoracic echocardiography will be performed to each individual and multiple criteria will be evaluated.In two-dimensional echocardiographic examination, left ventricular ejection fraction will be evaluated by M-mod and Simpson methods.

    3-months

Secondary Outcomes (2)

  • Six-minute walking test (meter)

    3-months

  • Quality of life

    3-months

Study Arms (2)

Tai Chi program

EXPERIMENTAL

Individuals in the intervention group will perform a 12-week Tai Chi exercise in company with a researcher.Following the warm-up movements (Qi-gong), the training protocol of the Tai Chi movements, which includes the 10-form Yang style, will continue for 12 weeks, with two sessions per week determined by the researchers.The first and second weeks of the exercise protocol will include introducing the Tai Chi philosophy and teaching 10 forms of Yang style to patients. For 12 weeks, individuals will practice 10 forms of Tai Chi exercises with a researcher in each session. Each session will be planned as one hour.

Other: Tai Chi exercise

Control group

OTHER

Individuals in the control group will be trained on heart failure. The only attempt to be made to the control group will be education.

Behavioral: Education (control group)

Interventions

Individuals in the intervention group will perform a 12-week Tai Chi exercise in company with a researcher.Following the warm-up movements (Qi-gong), the training protocol of the Tai Chi movements, which includes the 10-form Yang style, will continue for 12 weeks, with two sessions per week determined by the researchers.The first and second weeks of the exercise protocol will include introducing the Tai Chi philosophy and teaching 10 forms of Yang style to patients. For 12 weeks, individuals will practice 10 forms of Tai Chi exercises with a researcher in each session. Each session will be planned as one hour.

Tai Chi program

Individuals in the control group will also be trained on heart failure, which will be applied to individuals in the intervention group. The only attempt to be made to the control group will be education.

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years and over,
  • Diagnosed as chronic heart failure by the physician,
  • Left ventricular ejection fraction (LVEF) \<40%, proven by echocardiography in the past two years,
  • New York Heart Association (NYHA) class II and III,
  • Sinus rhythm is observed in electrocardiography (ECG),
  • Blood pressure values measured before Tai Chi session were 120-160 mmHg for systolic pressure and 80-110 mmHg for diastolic pressure,
  • No current anxiolytic or hypnotic treatment,
  • Have no psychiatric problems,
  • Verbal communication can be established,
  • Those who understand and speak Turkish,
  • No speech, hearing and vision loss,
  • There is no physical limitation that prevents the exercise of standing,
  • They have never experienced Tai Chi exercise before,
  • Individuals who volunteer to participate in the Tai Chi program during the study

You may not qualify if:

  • Having unstable angina pectoris, myocardial infarction or major cardiac surgery in the past three months,
  • Experiencing dyspnea and exercise tolerance that worsen during rest,
  • NYHA class I and IV,
  • Type B natriuretic peptide level measured in the last three months is 100 and above,
  • Blood pressure values measured before the Tai Chi session are\> 120 mmHg or \<160 mmHg for systolic pressure and\> 80 mmHg or \<110 mmHg for diastolic pressure,
  • Has hemodynamically significant heart valve disease,
  • Having dysrhythmia problems such as ventricular tachyarrhythmia, atrial fibrillation,
  • Has a history of cardiac resynchronization therapy in the past 3 months,
  • Having chronic diseases such as chronic pulmonary disease and renal failure,
  • With uncontrolled diabetes (Hemoglobin A1C ≥ 7 mg / dl),
  • Diagnosed with thrombophlebitis,
  • Has a history of cardiac transplantation and cardiac device therapy (cardiac pacemaker, implantable cardioverter defibrillator),
  • Having physical limitations that prevent standing exercise,
  • Do not understand and speak Turkish,
  • Speech, hearing and vision loss,
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bolu Abant Izzet Baysal University Izzet Baysal Training and Research Hospital

Bolu, Bolu, 14280, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Heart Failure

Interventions

Aquatic TherapyEducational StatusControl Groups

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

HydrotherapyPhysical Therapy ModalitiesTherapeuticsRehabilitationSocioeconomic FactorsPopulation CharacteristicsEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Şeyma Demir, Res. Assist.

    Bolu Abant Izzet Baysal University, Health Sciences Faculty

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assist

Study Record Dates

First Submitted

May 29, 2020

First Posted

June 24, 2020

Study Start

January 1, 2020

Primary Completion

April 1, 2021

Study Completion

December 21, 2021

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations